Anuncia Medical, Inc.

About

Anuncia Medical Inc. is an early-stage commercial, patient-centric MedTech company with US-cleared and EU-approved, clinically validated, noninvasive, therapeutic, and monitoring devices. We have a robust product pipeline to disrupt the Central Nervous System (CNS) space, with initial products to address CSF Management and Neurocritical Care. We uniquely address the largest unmet need in hydrocephalus, the high rate of ventriculoperitoneal (VP) shunt occlusion with our core ReFlow™ platform technology. VP shunts fail at a rate of 50% within 2 years and 80% within 5 years, contributing to repeat revision brain surgeries (each costing upwards of $40,000).

Business Hours